Alpha Cognition Inc (ACOG)

CSE
Currency in CAD
8.16
+0.91(+12.55%)
Closed·
Showing Alpha Cognition historical data. For real-time data please try another search
Day's Range
7.468.17
52 wk Range
7.2522.75
Key Statistics
Edit
Bid/Ask
0.23 / 0.28
Prev. Close
8.11
Open
7.71
Day's Range
7.46-8.17
52 wk Range
7.25-22.75
Volume
2.43K
Average Volume (3m)
2.83K
1-Year Change
-54.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
Show more

Alpha Cognition Inc Company Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer’s disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Earnings

Latest Release
Mar 31, 2025
EPS / Forecast
-0.50 / -0.0817
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

5.54
PTHL
+3.55%
8.08
EPWK
+2.02%
3.98
SAGT
+2.84%
1.69
GUTS
+2.42%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.